Hot Topics in Bladder and Prostate Cancer: Latest Treatments and Case-Based Learning
Join Us This Year in Dallas!
This December, we're hosting a comprehensive educational event in Dallas to help take your clinical practice to the next level. Pre-register today and join hundreds of other healthcare professionals like you!
Location: Sheraton Dallas Hotel in Dallas, Texas
Room: Dallas Ballroom D2
Key Takeaways:
- Friday, December 6 from 7:00 AM - 8:00 AM CT
- Earn up to 1.00 complimentary CME/CE credit
- Networking opportunities with like-minded peers
- Engage with experts in the field
- Cutting-edge research and a transformative learning experience
- Interactive session with live Q&A
Join Us This Year in Dallas!
This December, we're hosting a comprehensive educational event in Dallas to help take your clinical practice to the next level. Pre-register today and join hundreds of other healthcare professionals like you!
Location: Sheraton Dallas Hotel in Dallas, Texas
Room: Dallas Ballroom D2
Key Takeaways:
- Friday, December 6 from 7:00 AM - 8:00 AM CT
- Earn up to 1.00 complimentary CME/CE credit
- Networking opportunities with like-minded peers
- Engage with experts in the field
- Cutting-edge research and a transformative learning experience
- Interactive session with live Q&A
Learning Objectives:
- Describe diagnostic and prognostic biomarkers and emerging applications for next generation imaging in staging and treatment selection for MIBC, HER-2+ mUC and de novo mHSPC
- Evaluate recent clinical trial data and its implications for treatment selection and sequencing in MIBC, HER-2+ mUC and de novo mHSPC
- Evaluate the evolving landscape of neoadjuvant treatment in MIBC and de novo mHSPC treatment and the implications for patient care
- Implement the most current guideline recommendations and patient-centered care strategies to improve MIBC, mUC and de novo mHSPC diagnosis, treatment, and outcomes
Who Should Attend?
This educational activity is specifically designed for clinicians who specialize in urologic oncology involved and/or interested in the therapeutic management of patients with urologic malignancies and conditions.
Nationally-Recognized Speakers and Premier Education
-
Jason A. Efstathiou, MD
Director, Genitourinary (GU) Division
Co-Director, Bertucci Center for GU Cancers
Massachusetts General Hospital/Mass General Brigham
Boston, MA -
Daniel P. Petrylak, MD
Professor of Medicine (Medical Oncology) and of Urology
Yale School of Medicine
New Haven, CT -
Neal Shore, MD
Medical Director
Carolina Urologic Research Center
Myrtle Beach, SC
All of our symposia are offered at no additional cost to registered attendees of SUO.
Registering for the symposium helps us to ensure we have enough space for interested participants and allows us to send you reminders so you don’t forget about the session, but registration is not required.
Sessions will be available to watch on-demand 2-4 weeks following the SUO Symposium. Sessions can be accessed online at HMPeducation.com.
Commercial Support
This activity is supported by an independent educational grant from AstraZeneca.
This activity is supported by an independent educational grant from AstraZeneca.